Martine A. Rothblatt serves as Executive at UNITED THERAPEUTICS CORP, where they oversee executive responsibilities. Since joining the company, Martine A. Rothblatt has executed 4994 insider transactions totaling $1.1B, demonstrating a bearish approach to their equity position. Their most recent transaction on Mar 18, 2024 involved selling 6,627 shares valued at $1.6M.
Martine A. Rothblatt currently holds 130 shares of UNITED THERAPEUTICS CORP (UTHR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Martine A. Rothblatt has been a net seller of UTHR stock. They have purchased $15.1M and sold $1.0B worth of shares.
Martine A. Rothblatt's most recent insider trade was on Mar 18, 2024, when they sold 6,627 shares at $235.05 per share.
Get notified when new Form 4 filings are submitted
| $235.91 |
| Planned |
| Mar 15, 2024 | UTHR | $1.4M | Sale | 5,789 | $237.58 | Planned |
| Mar 15, 2024 | UTHR | $1.1M | Sale | 4,449 | $236.77 | Planned |
| Mar 15, 2024 | UTHR | $981.4K | Sale | 4,165 | $235.63 | Planned |
| Mar 15, 2024 | UTHR | $1.9M | Option Exercise | 15,000 | $129.49 | Planned |
| Mar 15, 2024 | UTHR | $142.5K | Sale | 597 | $238.68 | Planned |
| Mar 14, 2024 | UTHR | $304.7K | Sale | 1,267 | $240.47 | Planned |
| Mar 14, 2024 | UTHR | $738.8K | Sale | 3,098 | $238.49 | Planned |
| Mar 14, 2024 | UTHR | $1.4M | Sale | 5,955 | $237.62 | Planned |
| Mar 14, 2024 | UTHR | $38.1K | Sale | 158 | $241.41 | Planned |
| Mar 14, 2024 | UTHR | $1.1M | Sale | 4,522 | $236.74 | Planned |
| Mar 14, 2024 | UTHR | $1.9M | Option Exercise | 15,000 | $129.49 | Planned |
| Mar 13, 2024 | UTHR | $50.9K | Sale | 205 | $248.42 | Planned |
| Mar 13, 2024 | UTHR | $86.8K | Sale | 351 | $247.19 | Planned |
| Mar 13, 2024 | UTHR | $294.2K | Sale | 1,195 | $246.17 | Planned |
| Mar 13, 2024 | UTHR | $47.0K | Sale | 192 | $244.90 | Planned |
| Mar 13, 2024 | UTHR | $872.4K | Sale | 3,581 | $243.63 | Planned |
| Mar 13, 2024 | UTHR | $884.3K | Sale | 3,645 | $242.60 | Planned |
| Mar 13, 2024 | UTHR | $755.5K | Sale | 3,127 | $241.61 | Planned |
| Mar 13, 2024 | UTHR | $650.8K | Sale | 2,704 | $240.69 | Planned |
| Mar 13, 2024 | UTHR | $1.9M | Option Exercise | 15,000 | $129.49 | Planned |
| Mar 12, 2024 | UTHR | $192.9K | Sale | 772 | $249.82 | Planned |
| Mar 12, 2024 | UTHR | $1.9M | Option Exercise | 15,000 | $129.49 | Planned |
| Mar 12, 2024 | UTHR | $1.8M | Sale | 7,091 | $247.20 | Planned |
| Mar 12, 2024 | UTHR | $1.1M | Sale | 4,443 | $248.09 | Planned |
| Mar 12, 2024 | UTHR | $671.2K | Sale | 2,694 | $249.15 | Planned |
| Mar 11, 2024 | UTHR | $871.8K | Sale | 3,531 | $246.91 | Planned |
| Mar 11, 2024 | UTHR | $279.8K | Sale | 1,137 | $246.05 | Planned |
| Mar 11, 2024 | UTHR | $596.2K | Sale | 2,404 | $247.99 | Planned |